• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec12
Insiders at Set Med sold $554,965 worth of shares
21:23
Dec9
Citizens Maintains Incyte's Market Performance Rating
12:32
Dec8
Inteum Therapeutics INCA033989 reports positive data at ASH and receives FDA Breakthrough Therapy Designation
21:43
Wells Fargo Raises Incyte's Target Price
16:36
Barclays analyst maintains buy rating for InSightec
08:47
Dec7
FDA Grants Incyte's INCA033989 Breakthrough Therapy Designation
14:30

Schedules & Filings

Schedules
Filings
Oct28
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.366 B, Net Income 424.17 M, EPS 2.11

Jul29
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.216 B, Net Income 405 M, EPS 2.04

Apr29
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.053 B, Net Income 158.2 M, EPS 0.8

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More